Navigation Links
CWRU team building an MRI-guided robotic heart catheter
Date:11/11/2013

In a matter of years, a doctor may see real-time images of a patient's beating heart and steer a robotic catheter through its chambers using the push and pull of magnetic fields while the patient lies inside a magnetic resonance imager.

Researchers at Case Western Reserve University have received a $1.3 million grant from the National Institutes of Health to perfect such technology over the next four years.

The project aims to improve treatment of arterial fibrillationan irregular beat that occurs when electrical conductivity in the heart short-circuits and can lead to a stroke or heart disease.

To treat the problem, doctors slip a catheter through a vein in the thigh up into the heart, where an electrode tip is used to burn, or ablate, the tissues involved in the short-circuiting. When successful, this allows the heart's electrical currents to travel smoothly, resulting in normal beating and blood flow.

But doctors sometimes have trouble maintaining contact with the target tissue. A beating heart moves the target, and flowing blood creates turbulence similar to airplanes through wind currents. The two-dimensional view produced through fluoroscopy imaging is often grainy or blurry. The result is surgeons sometimes burn more tissue than necessary, or not enough to eliminate the problem.

"With our technologies, we believe physicians will be able to accurately navigate and target tissues; they will see exactly where they are inside the heart in real time and see the tissues they are ablating in real time," said M. Cenk Cavusoglu, professor of electrical engineering and computer science and principal investigator on the project.

Doctors will still hand-feed the catheter from thigh to heart. But once there, the robotics will take over, Cavusoglu said.

To make a catheter robotic, the researchers have wrapped the inch behind the tip in tiny copper coils. By passing an electrical current through them, the
'/>"/>

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Building the European Unions Natura 2000 -- the largest ever network of protected areas
2. New study finds a protein combination is best to consume post-workout for building muscle
3. Light weights are just as good for building muscle, getting stronger, researchers find
4. CUNY Energy Institute battery system could reduce buildings electric bills
5. A cells first steps: Building a model to explain how cells grow
6. Stealing lifes building blocks
7. Blood-brain barrier building blocks forged from human stem cells
8. Building global collaboration for biodiversity intelligence
9. Mathematicians find solution to biological building block puzzle
10. Minimally invasive building renovation
11. Natural regeneration building urban forests, altering species composition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... JOSE, Calif. , March 2, 2015 /PRNewswire/ ... the leading developer of human interface solutions, today ... technology that is designed to enable rapid and ... Natural ID™ module for gaming is a turnkey ... ODMs the ability to quickly integrate fingerprint ID ...
(Date:3/2/2015)... VILNIUS, Lithuania , March 2, 2015   ... AI technologies, today introduced the SentiGaze Software Development ... developers to create applications that use off-the-shelf webcams to ... a user gazes at a monitor. Heatmaps can be ... determining the effectiveness of online advertising. The SDK can ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... a new location or go extinct as a result of ... Northern England seem to defy the odds and adapt to ... study by scientists from Syracuse University and the University of ... of the Early Edition of the Proceedings of the ...
... -- The Soil Science Society of America (SSSA) applauds ... his colleagues in the Senate who helped usher in ... placing soil on par with water and air. ... Senators Kent Conrad (D-ND), Charles Grassley (R-IA), Russ Feingold ...
... lenses are joining the trend to go green. Chemical ... fluid found in our bodies can be used as a ... step up from the current wave of self-moisturizing contact lenses ... eye dryness and increase wearer comfort. It is estimated ...
Cached Biology News:New study finds that some plants can adapt to widespread climate change 2Senate resolution shines spotlight on the importance of soils 2Self-moisturizing contact lenses, naturally 2
(Date:3/30/2015)... With recent advancements in residential solar power ... companies are getting into the Solar Energy wave. ... renewable energy production, many homeowners are looking to residential ... a new solar distribution company in California which has ... homeowners to enjoy the benefits of solar energy without ...
(Date:3/30/2015)... , March 30, 2015  Heidrick & Struggles (Nasdaq: ... leadership consulting and culture shaping worldwide, ... firm to lead its global Healthcare and Life Sciences practice. ... Life Sciences, Mitchell will lead a team of more than ... Europe and Asia serving ...
(Date:3/30/2015)... , March 30, 2015 US-Australian drug ... and its subsidiary, CanTx, Inc., and Yale University, on ... Cantrixil. The data was presented as an oral presentation ... Yale Medical School to the 62 nd Annual ... San Francisco, CA. ...
(Date:3/30/2015)...    Intrexon Corporation (NYSE: XON ... Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... exclusive strategic collaboration and license agreement to develop ... therapies. This collaboration advances Merck Serono,s comprehensive, science-driven ... immune system,s natural ability to fight tumors. ...
Breaking Biology Technology:Solara Power Announces Residential Solar Power with No Up-Front Fees 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... 27, 2008 - Vol. 299. No. 8: ,Venous Thromboembolism ... Administration for the Treatment of ... Biotech believes that,the conclusions of a study published in ... American Medical Association (JAMA) by Bennett, et al, do,not ...
... Colo., Feb. 26 Replidyne, Inc.,(Nasdaq: RDYN ) today ... ended December 31, 2007., Replidyne reported a net loss ... or a net loss per basic and diluted common share,of ... million, or $0.36 per,basic and diluted common share, for the ...
... Firms Recommend Pharmion ... merger with Celgene Special Meeting ... Corp. Urges All Shareholders to Vote FOR the Proposed Merger, ... ) today announced that Institutional Shareholder Services,(ISS) has recommended that ...
Cached Biology Technology:Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 2Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 3Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 4Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 5Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3
... against Nonmuscle Myosin II Heavy Chain ... in TBS + 0.03% Thimerosal) This ... SDVNETQPPQSE corresponding to the C-terminus of ... (MHC-B) This antibody is effective in ...
... Factor XIII in both reduced and non-reduced forms. ... B-chain or human Factor XII. Factor XIII is ... of two subunits. Factor XIII-A is the catalytic ... Factor XIII is present in plasma as an ...
... 'The DNAscope V is a ... microarray scanning and image processing that deliver ... V is a high quality microarray scanner ... imaging technology for optimal background rejection and ...
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... NaCl, 10 mM sodium HEPES, ... pH 7.5. Recognizes the ~47 ... 2 (MAPKAPK-2) protein phosphorylated at ...
Biology Products: